Your browser is no longer supported. Please, upgrade your browser.
Trinity Biotech plc
Index- P/E- EPS (ttm)-0.29 Insider Own11.20% Shs Outstand20.90M Perf Week13.71%
Market Cap70.21M Forward P/E10.63 EPS next Y0.32 Insider Trans0.00% Shs Float15.85M Perf Month-12.37%
Income-6.00M PEG- EPS next Q0.07 Inst Own32.40% Short Float2.15% Perf Quarter-46.03%
Sales102.00M P/S0.69 EPS this Y79.30% Inst Trans2.14% Short Ratio0.92 Perf Half Y17.65%
Book/sh-0.11 P/B- EPS next Y0.00% ROA-4.90% Target Price- Perf Year139.44%
Cash/sh1.32 P/C2.57 EPS next 5Y15.00% ROE-520.60% 52W Range1.21 - 6.82 Perf YTD-10.76%
Dividend- P/FCF2.95 EPS past 5Y-18.70% ROI0.70% 52W High-50.16% Beta1.66
Dividend %- Quick Ratio2.00 Sales past 5Y0.40% Gross Margin47.60% 52W Low180.99% ATR0.28
Employees543 Current Ratio3.10 Sales Q/Q54.00% Oper. Margin0.10% RSI (14)48.00 Volatility12.39% 7.67%
OptionableYes Debt/Eq- EPS Q/Q58.80% Profit Margin-6.30% Rel Volume0.79 Prev Close3.36
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume369.17K Price3.40
Recom- SMA201.37% SMA50-10.77% SMA200-3.98% Volume289,999 Change1.19%
Oct-23-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Initiated Raymond James Outperform
Jul-29-15Reiterated ROTH Capital Buy $22 → $20
Jul-22-08Reiterated Roth Capital Buy $7 → $6
Mar-17-08Reiterated Roth Capital Buy $10.50 → $7
Dec-10-07Reiterated Roth Capital Buy $11.50 → $10.50
Oct-26-07Reiterated Roth Capital Buy $13 → $11.50
Mar-30-21 09:00AM  
Mar-25-21 09:28AM  
Mar-23-21 04:15PM  
Mar-17-21 07:46AM  
Feb-05-21 08:54AM  
Jan-05-21 08:04AM  
Dec-22-20 05:43AM  
Nov-27-20 11:28AM  
Nov-17-20 09:15AM  
Nov-04-20 11:32AM  
Oct-29-20 10:38AM  
Sep-15-20 02:43PM  
Aug-25-20 09:40AM  
Aug-20-20 10:31AM  
Aug-18-20 08:04AM  
Aug-17-20 11:59AM  
Jul-23-20 08:40PM  
Jun-02-20 06:17AM  
May-27-20 10:11AM  
May-14-20 07:25AM  
Apr-02-20 08:30AM  
Mar-31-20 09:09AM  
Mar-24-20 10:08AM  
Feb-28-20 12:53PM  
Feb-17-20 02:55PM  
Dec-22-19 05:10PM  
Dec-17-19 09:39AM  
Oct-21-19 03:38PM  
Oct-17-19 07:39AM  
Oct-16-19 08:04AM  
Oct-15-19 11:40AM  
Oct-11-19 12:06PM  
Sep-05-19 08:36AM  
Sep-04-19 07:11PM  
Aug-21-19 07:40AM  
Aug-20-19 08:22AM  
Aug-15-19 02:07PM  
Jul-31-19 08:12AM  
May-15-19 12:13PM  
May-07-19 08:26AM  
May-01-19 10:19AM  
Apr-25-19 04:27PM  
Apr-12-19 11:59AM  
Mar-04-19 05:00AM  
Feb-25-19 02:55PM  
Dec-25-18 12:07PM  
Dec-13-18 01:49AM  
Nov-29-18 08:58AM  
Nov-02-18 03:40PM  
Oct-26-18 09:55PM  
Oct-23-18 08:05AM  
Oct-16-18 05:35AM  
Sep-18-18 09:54AM  
Jul-21-18 08:53AM  
Jul-19-18 08:25AM  
Jul-18-18 04:35PM  
Jul-12-18 10:17AM  
Jun-25-18 02:01PM  
Jun-06-18 08:45AM  
May-22-18 03:13PM  
May-01-18 09:07AM  
Apr-20-18 10:42AM  
Mar-08-18 02:21PM  
Mar-07-18 09:11AM  
Mar-05-18 08:37AM  
Dec-12-17 12:26PM  
Nov-17-17 06:31AM  
Nov-01-17 09:39AM  
Oct-26-17 08:25AM  
Oct-13-17 04:54AM  
Aug-12-17 09:16PM  
Aug-10-17 06:37PM  
Jul-26-17 11:43AM  
Jul-20-17 08:28AM  
Jul-03-17 07:57AM  
May-29-17 12:41PM  
May-22-17 06:10PM  
May-03-17 10:06AM  
May-01-17 02:55PM  
Apr-27-17 10:15AM  
Apr-18-17 06:10AM  
Mar-14-17 07:45PM  
Mar-01-17 02:34PM  
Feb-24-17 06:52AM  
Jan-05-17 05:30PM  
Dec-15-16 08:46AM  
Dec-09-16 04:51PM  
Dec-08-16 05:24PM  
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. The company sells its products through its direct sales force; and a network of independent distributors and strategic partners. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.